• Improving In Vitro Assessment of Anti-Cancer Drug Responses

  2026-07-09

  Schwartz’s dissertation advances in vitro drug response evaluation by distinguishing between relative and fractional viability, providing a more granular understanding of anti-cancer drug effects. This approach informs more accurate assessments of agents like Tivozanib (AV-951) in oncology research.

• Distinct Apoptosis Pathways in BMECs Triggered by Candida kr

  2026-07-09

  Miao et al. (2023) reveal that Candida krusei induces apoptosis in bovine mammary epithelial cells via distinct signaling pathways dependent on its morphological phase. These mechanistic insights clarify the pathogen’s contribution to bovine mastitis and offer a foundation for targeted intervention and research into caspase-dependent cell death.

• Exo1: Mechanistic Precision for Translational Exocytosis Res

  2026-07-08

  Explore how Exo1 (methyl 2-(4-fluorobenzamido)benzoate) transforms exocytic pathway studies with acute, ARF1-centric inhibition, empowering translational researchers to dissect tumor extracellular vesicle dynamics and membrane trafficking with unprecedented specificity. This article integrates recent advances in tumor metastasis blockade, practical protocol guidance, and strategic perspectives for the future of exocytic pathway research.

• Neuromedin S (rat): Protocol Parameters and Workflow Guidanc

  2026-07-08

  Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for selective activation of neuromedin U receptor signaling in rat-based GPCR/G protein workflows. It addresses the need for reproducible, controlled studies in areas such as energy homeostasis regulation and stress response research. This product is not suitable for diagnostic or therapeutic use and should be applied strictly within validated research protocols.

• Treponema pallidum Triggers Intrinsic Apoptosis via Mitochon

  2026-07-07

  This study reveals that Treponema pallidum induces intrinsic apoptosis in hepatocytes by promoting mitochondrial ROS accumulation and cardiolipin peroxidation. These findings clarify mitochondrial permeability transition pore (MPTP) involvement in syphilitic liver damage, with broad implications for cell death mechanism research.

• Syringin Targets EGFR/PI3K/Akt to Enhance RCC Therapy Effica

  2026-07-07

  This study identifies Syringin as a bioactive natural product that inhibits renal cell carcinoma (RCC) cell growth and enhances the sensitivity of RCC cells to sunitinib by targeting the EGFR/PI3K/Akt pathway. The findings provide mechanistic insight into overcoming drug resistance in RCC and inform the design of future bioactive compound screening strategies.

• LY2603618 in Synthetic Lethality: Redefining Chk1 Inhibitor

  2026-07-06

  Explore how LY2603618, a potent Chk1 inhibitor, enables next-generation synthetic lethality strategies in cancer research. This article delivers unique insight into its mechanistic interplay with DNA damage pathways and practical optimization for advanced oncology assays.

• Tiamulin (Thiamutilin): Optimizing Veterinary and Bench Work

  2026-07-06

  Tiamulin (Thiamutilin) delivers dual antibacterial and anti-inflammatory activity, redefining protocols for veterinary infectious diseases and translational research. This article translates molecular insights into actionable workflows, troubleshooting strategies, and advanced applications for researchers and veterinarians.

• Hydroxychloroquine Sulfate: Protocols for Autoimmune Disease

  2026-07-05

  Hydroxychloroquine Sulfate (SKU B4874) provides targeted inhibition of autophagy and toll-like receptor signaling, addressing key requirements in autoimmune disease research workflows. It is best suited for aqueous-based protocols and short-term solution use, but is not recommended where organic solvent compatibility or extended storage of stock solutions is necessary.

• Cefoperazone Sodium Salt: β-Lactamase Stability & Research V

  2026-07-04

  Cefoperazone sodium salt is a semisynthetic cephalosporin antibiotic with broad-spectrum antibacterial activity and high β-lactamase stability. Its performance in in vitro and in vivo models supports research on gram-negative resistance and biliary tract infections. This article details its mechanism, benchmarks, and optimal use in translational workflows.

• CCL7+ Macrophages Drive Immunotherapy Resistance in Colorect

  2026-07-03

  A recent study uncovers how CCL7-expressing tumor-associated macrophages mediate immunotherapy resistance in colorectal cancer by modulating immune cell infiltration and metabolic pathways. These insights highlight novel therapeutic targets and experimental strategies for dissecting macrophage-driven immune evasion.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-07-03

  The reference study demonstrates that HOXC8, a homeobox transcription factor, acts as a suppressor of pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 expression. These findings reveal a novel epigenetic mechanism linking HOXC8 and HDAC1/2 to inflammasome-independent pyroptosis, offering new insight into tumorigenesis and potential therapeutic targets.

• SB743921: Kinesin Spindle Protein Inhibitor Workflows in Can

  2026-07-02

  SB743921 is a highly selective kinesin spindle protein inhibitor that delivers nanomolar precision in arresting mitosis and inducing apoptosis in cancer cells. This article demystifies experimental workflows, advanced applications, and troubleshooting strategies, empowering researchers to maximize assay reproducibility and translational relevance using SB743921 from APExBIO.

• Targeting Glutamine Metabolism in Hepatic Stellate Cells to

  2026-07-02

  The reference study uncovers how targeting glutamine metabolism, specifically via SIRT4-mediated inhibition of glutamate dehydrogenase (GDH), suppresses hepatic stellate cell activation and mitigates liver fibrosis. These findings highlight new metabolic targets for antifibrotic therapy and broaden mechanistic understanding of chronic liver disease progression.

• Refining In Vitro Drug Response Metrics for Cancer Research

  2026-07-01

  Schwartz's dissertation advances in vitro anti-cancer drug evaluation by distinguishing between proliferation inhibition and cell death, providing more nuanced and predictive assessments of drug efficacy. These findings inform the design and interpretation of apoptosis inhibitor research, potentially improving translational relevance for preclinical cancer models.

454 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page